SCHEMBL30359207

SCHEMBL30359207

NCC(F)(F)CCc1c[nH]c2cccc(OCc3ccccc3)c12

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.61
TRPM8 Q7Z2W7 2/20 0.47
LTA4H P09960 2/20 0.47
PLA2G2A P14555 2/20 0.47
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HTR6 P50406 1/20 0.39
MITF O75030 1/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
HTR2C P28335 1/20 0.38
DCPS Q96C86 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23805211 0.84 HTR2A (0.71) HTR2ATRPM8LTA4HPLA2G2AMAPT
Hydrochloric Acid SCHEMBL274592 0.83 HTR2A (0.70) HTR2ATRPM8LTA4HPLA2G2AMAPT
SCHEMBL11263785 0.81 HTR2A (0.67) HTR2ATRPM8LTA4HPLA2G2AMAPT
SCHEMBL31295159 0.79 HTR2A (0.71) HTR2ATRPM8LTA4HPLA2G2AMAPT
SCHEMBL31295123 0.79 HTR2A (0.71) HTR2ATRPM8LTA4HPLA2G2AMAPT
SCHEMBL23805285 0.79 HTR2A (0.60) HTR2ATRPM8LTA4HPLA2G2AMAPT
SCHEMBL23805245 0.77 HTR2A (0.72) HTR2ATRPM8LTA4HPLA2G2AMAPT
SCHEMBL6615000 0.77 HTR2A (0.68) HTR2ATRPM8LTA4HPLA2G2AMTNR1A
SCHEMBL30249165 0.77 HTR2A (0.67) HTR2ATRPM8LTA4HPLA2G2AMAPT
SCHEMBL23805297 0.76 HTR2A (0.67) HTR2ATRPM8LTA4HPLA2G2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230140635-A1 3-(2-(Aminoethyl)-Indol-4-ol Derivatives, Methods of Preparation Thereof, and the Use as 5-HT2 Receptor Modulators BRIGHT MINDS BIOSCIENCES INC. (CA) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230140635-A1 3-(2-(Aminoethyl)-Indol-4-ol Derivatives, Methods of Preparation Thereof, and the Use as 5-HT2 Receptor Modulators HTR2C, HTR2A, HTR2B HTR2A 2/4885TRPM8 379/4885LTA4H 350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.